Table 1.
Characteristics of study subjects.
Baseline | HC group (n = 60) | AG group (n = 68) | GC group (n = 135) | P |
---|---|---|---|---|
Age (yr) | 64.55 ± 13.32 | 62.56 ± 11.55 | 64.79 ± 12.36 | .464 |
Gender | .237 | |||
Female | 33 | 35 | 58 | |
Male | 27 | 33 | 77 | |
Sirt6 (ng/mL) | 35.01 ± 7.30 | 25.13 ± 6.84 | 19.09 ± 5.36 | <.001 |
CEA (ng/mL) | 2.15 ± 1.15 | 3.56 ± 1.50 | 3.89 ± 1.59 | <.001 |
CA 19-9 (U/mL) | 14.04 ± 4.46 | 14.60 ± 3.94 | 17.81 ± 4.79 | <.001 |
CA 72-4 (IU/mL) | 5.37 ± 1.43 | 7.11 ± 1.60 | 8.43 ± 2.18 | <.001 |
CA 125 (IU/mL) | 33.49 ± 14.03 | 36.96 ± 9.49 | 38.42 ± 7.42 | .006 |
CA 50 (µg/L) | 21.99 ± 4.76 | 22.93 ± 4.96 | 25.44 ± 4.66 | <.001 |
AG = atrophic gastritis, CA 19-9 = carbohydrate antigen 19-9, CA 72-4 = carbohydrate antigen 72-4, CEA = carcino-embryonic antigen, Sirt6 = sirtuin 6.